Mentia awarded USD492K from the NIH_NIA(SBIR) to conduct Phase I Clinical Trial to measure DevaWorld efficacy
We are excited to share the news that earlier this month, Mentia was awarded a $492,000 Small Business Innovation Research (SBIR) grant from the National Institute on Aging of the National Institute of Health (USA). Funds will be used to conduct a Phase I clinical trial that measures DevaWorld’s capacity to assist persons living with dementia to undertake self-care activities of daily living with greater confidence and self-determination while reducing care challenges for care staff and families.
We are thrilled to work on this grant with our site partners Menorah Center for Rehabilitation and Nursing Care, NY and Elder Ashram, CA. Guiding us on this journey are the distinguished research professors Mary Mittelman Ph.D., NYU, and Laura N. Gitlin Ph.D., Dean of Nursing and Health Professions at Drexel University.
We wish to acknowledge the NIA at the NIH’s project team for advancing research in the care of those impacted by Alzheimer’s Disease and Related Dementias. Work begins immediately, and runs for 12 months.